Luncheon Seminar

[LS-31] Luncheon Seminar 31

Updates in MAO-B inhibitors for Parkinson's disease treatment

Fri. May 24, 2019 11:30 AM - 12:30 PM Room 9 (Osaka International Convention Center 12F Conference Hall)

Chair:Hidefumi Ito(Department of Neurology, Wakayama Medical University)

FP Pharmaceutical Corporation

Luncheon Seminar

[LS-32] Luncheon Seminar 32

Up to Date of the Treatment in Patients with TSC

Fri. May 24, 2019 11:30 AM - 12:30 PM Room 10 (Osaka International Convention Center 12F Grande Toque)

Chair:Naoki Akamatsu(Department of Neurology, International University of Health and Welfare/ Neuroscience Center, Fukuoka Sanno Hospital)

Novartis Pharma K.K.

Luncheon Seminar

[LS-33] Luncheon Seminar 33

Importance of early diagnosis and starting treatment in amyotrophic lateral sclerosis

Fri. May 24, 2019 11:30 AM - 12:30 PM Room 11 (Osaka International Convention Center 12F Conference Room 1202)

Chair:Takayoshi Shimohata(Department of Neurology and Geriatrics, Gifu University Graduate School of Medicine)

Mitsubishi Tanabe Pharma Corporation

Luncheon Seminar

[LS-34] Luncheon Seminar 34

Anticoagulant Therapy for AF Patients with Risk

Fri. May 24, 2019 11:30 AM - 12:30 PM Room 12 (Osaka International Convention Center 11F Conference Room 1101-1102)

Chair:Yasuyuki Iguchi(Professor, Department of Neurology, The Jikei University School of Medicine)

Bayer Yakuhin, Ltd.

Luncheon Seminar

[LS-35] Luncheon Seminar 35

Positioning of Levodopa carbidopa intestinal gel(LCIG) for advanced Parkinson's disease treatment from the evidences and clinical practices point of view

Fri. May 24, 2019 11:30 AM - 12:30 PM Room 13 (Osaka International Convention Center 8F Conference Room 801-802)

Chair:Masahiko Tomiyama(Hirosaki University, Graduate School of Medicine and School of Medicine)

AbbVie GK

Luncheon Seminar

[LS-36] Luncheon Seminar 36

Revisiting the “progression” in multiple sclerosis

Fri. May 24, 2019 11:30 AM - 12:30 PM Room 14 (Osaka International Convention Center 7F Conference Room 701-702)

Chair:Jin Nakahara(Professor and Chairman, Department of Neurology, Keio University School of Medicine)

Novartis Pharma K.K. Medical Division

Evening Seminar

[ES-03] Evening Seminar 03

Overview of the neuroimaging study useful for the differential diagnosis and the control of symptoms in dementia: Focusing on the case study by nuclear medicine

Fri. May 24, 2019 5:30 PM - 6:30 PM Room 5 (Osaka International Convention Center 10F Conference Room 1005-1007)

Chair:Yoshio Tsuboi(Professor, Department of Neurology, Fukuoka University)

FUJIFILM Toyama Chemical Co., Ltd.

Evening Seminar

[ES-04] Evening Seminar 04

Reveal the difference in cognitive impairment between MS and AD - Clinical features and exermination tools -

Fri. May 24, 2019 5:30 PM - 6:30 PM Room 6 (Osaka International Convention Center 10F Conference Room 1009)

Chair:Jun-ichi Kira(Department of Neurology, Kyushu University)

Biogen Japan Ltd. / Eisai Co., Ltd.

Evening Seminar

[ES-05] Evening Seminar 05

Seizure semiology deciphered from brain functional localization

Fri. May 24, 2019 5:30 PM - 6:30 PM Room 10 (Osaka International Convention Center 12F Grande Toque)

Chair:Riki Matsumoto(Division of Neurology, Kobe University Graduate School of Medicine)

DAIICHI SANKYO Co.,Ltd. / UCB Japan Co.,Ltd.

Evening Seminar

[ES-06] Evening Seminar 06

An alternative option for immunoglobulin maintenance therapy in CIDP: subcutaneous immunoglobulin

Fri. May 24, 2019 5:30 PM - 6:30 PM Room 11 (Osaka International Convention Center 12F Conference Room 1202)

Chair:Gen Sobue(Distinguished Professor, Nagoya University Graduate School of Medicine)

CSL Behring K.K.